Nuo Therapeutics, Inc. (AURX)

Cost of Revenue

$1.87M

TTM · Period ending: · USD

AURX logo

AURX Cost of Revenue

Latest reported$1.87M
AURX TTM Cost of Revenue ($61.95K → $1.87M)
High-resolution chart · PNG

AURX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nuo Therapeutics, Inc. Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
1,866,529
1,426,920
1,095,553
773,504
467,287
373,272
302,842
257,798
211,112
166,264
126,092
97,443
50,120
30,989
20,570
7,851
1,356
0
0
0
0
17,576
52,285
85,915
114,614
127,948
138,095
142,688
162,993
411,674
630,811
869,959
1,091,042
1,087,085
1,100,695
1,093,601
1,612,688
2,496,957
3,819,427
5,930,947
7,967,110
8,893,090
8,627,319
8,143,015
6,770,743
7,657,073
9,172,661
8,633,813
8,453,192
6,569,124
4,717,169
4,338,550
3,914,542
3,552,107
3,271,007
2,930,208
2,727,156
2,569,112
2,386,726
2,432,777
1,961,836
1,498,494
1,067,566
500,261
458,805
521,817
527,219
515,847
601,020
638,368
675,546
831,575
850,285
950,020
1,027,237
987,893
1,014,585
1,037,761
1,009,725
990,445
881,324
762,049
719,401
660,624
711,827
698,083
723,308
771,805
758,433
580,179
431,972
254,319
62,047
45,725
16,073
0
1,163,093
1,172,878
1,188,718
1,219,809
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.